A detailed history of Advisor Group Holdings, Inc. transactions in Geron Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 191,817 shares of GERN stock, worth $642,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
191,817
Previous 189,548 1.2%
Holding current value
$642,586
Previous $803,000 8.34%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.17 - $4.99 $9,461 - $11,322
2,269 Added 1.2%
191,817 $870,000
Q2 2024

Aug 13, 2024

SELL
$3.1 - $5.09 $243,827 - $400,348
-78,654 Reduced 29.33%
189,548 $803,000
Q1 2024

May 10, 2024

BUY
$1.75 - $3.44 $71,743 - $141,026
40,996 Added 18.04%
268,202 $885,000
Q4 2023

Feb 12, 2024

SELL
$1.74 - $2.31 $125,226 - $166,248
-71,969 Reduced 24.06%
227,206 $479,000
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $154,996 - $240,942
73,458 Added 32.54%
299,175 $634,000
Q2 2023

Aug 21, 2023

SELL
$1.97 - $3.69 $1,759 - $3,295
-893 Reduced 0.39%
225,717 $724,000
Q2 2023

Aug 10, 2023

BUY
$1.97 - $3.69 $15,352 - $28,756
7,793 Added 3.56%
226,610 $727,000
Q1 2023

May 12, 2023

BUY
$2.14 - $3.4 $20,768 - $32,997
9,705 Added 4.64%
218,817 $474,000
Q4 2022

Feb 10, 2023

BUY
$2.03 - $2.42 $10,003 - $11,925
4,928 Added 2.41%
209,112 $506,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $23,555 - $41,468
14,105 Added 7.42%
204,184 $478,000
Q2 2022

Aug 10, 2022

BUY
$1.19 - $1.65 $24,990 - $34,650
21,000 Added 12.42%
190,079 $296,000
Q1 2022

May 04, 2022

SELL
$0.99 - $1.6 $5,940 - $9,600
-6,000 Reduced 3.43%
169,079 $230,000
Q3 2021

Nov 05, 2021

BUY
$1.2 - $1.5 $13,176 - $16,470
10,980 Added 6.69%
175,079 $240,000
Q2 2021

Aug 02, 2021

BUY
$1.25 - $1.83 $87,515 - $128,121
70,012 Added 74.41%
164,099 $231,000
Q1 2021

May 13, 2021

SELL
$1.52 - $2.1 $2,368 - $3,271
-1,558 Reduced 1.63%
94,087 $149,000
Q4 2020

Feb 10, 2021

BUY
$1.55 - $2.05 $2,244 - $2,968
1,448 Added 1.54%
95,645 $153,000
Q3 2020

Nov 12, 2020

BUY
$1.59 - $2.19 $14,416 - $19,856
9,067 Added 10.65%
94,197 $164,000
Q2 2020

Aug 14, 2020

BUY
$1.05 - $2.18 $13,765 - $28,579
13,110 Added 18.2%
85,130 $186,000
Q1 2020

May 18, 2020

BUY
$0.89 - $1.49 $64,097 - $107,309
72,020 New
72,020 $84,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.